Marianne Ellen Pavel



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS) (2026) Deroose CM, Leupe H, Hicks RJ, Virgolini I, Braat AJ, Mittra ES, Albert NL, et al. Journal article, Review article [177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2–3, gastroenteropancreatic neuroendocrine tumours: preplanned and post-hoc efficacy analyses from the randomised, phase 3 NETTER-2 trial (2026) Ferone D, Pavel ME, Herrmann K, Kunz PL, Myrehaug S, Halperin D, Chasen B, et al. Journal article [177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial (2026) Walter T, Jann H, Ansquer C, Deshayes E, Garcia-Carbonero R, Teulé A, Baum RP, et al. Journal article Clinical presentation and outcomes of sporadic neuroendocrine neoplasms in young adults (2026) Malczewska-Herman A, Rinke A, Holmager P, Opalińska M, McNamara MG, Netto D, Tesselaar ME, et al. Journal article Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas (2026) Hernandez-Felix JH, Golagha M, Jha A, Varghese D, Grozinsky-Glasberg S, Riechelmann R, Fazio N, et al. Journal article, Review article EWSR1::BEND2 gene fusions characterize a majority of ACTH-producing neuroendocrine neoplasms of the pancreas: A follow-up study and brief review of the recent literature (2026) Agaimy A, Adsay V, Stöhr R, Pavel ME, Lena MS Journal article, Report Gastroenteropancreatic neuroendocrine neoplasms in children and adults: a comparative review (2026) Kuhlen M, Claus R, Pavel ME, Kunstreich M, Begum N, Lapa C, Redlich A Journal article, Review article Clinical Impact of Molecular Tumor Board Inclusion on Treatment Outcomes in Neuroendocrine Neoplasms (2026) Barsch M, Gräßel L, Metzger P, von Werder A, Ganz J, Klaas L, Schulz L, et al. Journal article EndoCompass project: Research roadmap for pituitary and neuroendocrine tumor endocrinology (2025) Castano JP, Dattani MT, Grozinsky-Glasberg S, Karavitaki N, Pavel ME, Andoniadou C, Alexandraki K, et al. Journal article, Review article Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD? (2025) Schubart C, Tögel L, Carta MG, Hetzner P, Helbig L, Zaglas C, Ziegler M, et al. Journal article